Risultati della ricerca - Matthias Pinter
- Mostra 1 - 7 risultati su 7
-
1
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma Autoría: Katharina Pomej, Lorenz Balcar, Sabrina Sidali, Riccardo Sartoris, Tobias Meischl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Maxime Ronot, Mohamed Bouattour, Matthias Pinter, Bernhard Scheiner
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease Autoría: Nina Dominik, Lorenz Balcar, Georg Semmler, Benedikt Simbrunner, Michael Schwarz, Benedikt S. Hofer, Lukas Hartl, Mathias Jachs, Bernhard Scheiner, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Alexander Pilger, Thomas Reiberger
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply Autoría: Nina Dominik, Lorenz Balcar, Georg Semmler, Benedikt Simbrunner, Michael Schwarz, Benedikt S. Hofer, Lukas Hartl, Mathias Jachs, Bernhard Scheiner, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Alexander Pilger, Thomas Reiberger
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis Autoría: Nina Dominik, Benedikt Simbrunner, Bernhard Scheiner, Michael Schwarz, Lukas Hartl, Mathias Jachs, Lorenz Balcar, Georg Semmler, Georg Kramer, Christian Sebesta, Michael Trauner, Matthias Pinter, Mattias Mandorfer, Thomas Reiberger, Benedikt Silvester Hofer
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
5
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and D... Autoría: Mathias Jachs, Tânia Carvalho, Benedikt Simbrunner, Georg Semmler, Lukas Hartl, Lorenz Balcar, Benedikt Silvester Hofer, Paul Thöne, Nina Dominik, Georg Kramer, Christian Sebesta, Michael Schwarz, David Bauer, Albert F. Stättermayer, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
6
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort Autoría: Najib Ben Khaled, Valentina Zarka, Bernard Hobeika, Julia Schneider, Monika Rau, Alexander Weich, Hans Benno Leicht, Liangtao Ye, Ignazio Piseddu, Michael T. Dill, Arne Kandulski, Matthias Pinter, Ursula Ehmer, Peter Schirmacher, Jens U. Marquardt, Julia Mayerle, Enrico N. De Toni, Andreas Geier, Florian P. Reiter
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
7
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma—Data From the Multinational LITCHI Registry Autoría: Ulrike Bauer, Maria R. Troppmair, Najib Ben Khaled, Julia M. Grottenthaler, Friedrich Foerster, Sena Blümel, Sophia Heinrich, Friedrich Sinner, Matthias Pinter, Magdalena Hahn, Florian van Bömmel, Bernhard Scheiner, Marino Venerito, Richard Taubert, Andreas E. Kremer, Arndt Weinmann, Christoph P. Berg, Christian M. Lange, Enrico N. De Toni, Angela Djanani, Heinz Zoller, Roland M. Schmid, Ursula Ehmer
Pubblicazione 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso